Pulse Biosciences, Inc.
PLSE US74587B1017
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -40% | -81% | 345% | 58% | 10% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Danahy Kevin Patrick CCO |
18.53 USD |
4,600 Sold |
85,238 USD |
02/10/2025 | 02/10/2025 |
| Danahy Kevin Patrick CCO |
18.48 USD |
400 Sold |
7,392 USD |
18/09/2025 | 19/09/2025 |
| Danahy Kevin Patrick CCO |
18.49 USD |
20,000 Sold |
369,800 USD |
18/09/2025 | 18/09/2025 |
| Uecker Darrin CTO |
16.21 USD |
20,000 Sold |
324,200 USD |
16/09/2025 | 17/09/2025 |
| Uecker Darrin CTO |
16.28 USD |
25,000 Sold |
407,000 USD |
16/09/2025 | 16/09/2025 |
| Uecker Darrin CTO |
15.77 USD |
25,000 Sold |
394,250 USD |
11/09/2025 | 15/09/2025 |
| Uecker Darrin CTO |
14.32 USD |
25,000 Sold |
358,000 USD |
11/09/2025 | 12/09/2025 |
| Uecker Darrin CTO |
14.78 USD |
25,000 Sold |
369,500 USD |
11/09/2025 | 11/09/2025 |
| Duggan Robert W |
14.66 USD |
34,659 Bought |
508,101 USD |
10/09/2025 | 10/09/2025 |
| Uecker Darrin CTO |
15.98 USD |
15,000 Sold |
239,700 USD |
12/06/2025 | 13/06/2025 |